Jun 17, 2020
Fresenius Kidney Care Transforms Continuum of Patient Care by Expanding Network of Transitional Care Units
Jun 15, 2020
Ardelyx Announces Positive Second Data Analysis from Ongoing NORMALIZE Phase 4 Study Evaluating Tenapanor in CKD Patients on Dialysis
Jun 12, 2020
KidneyIntelX(TM) Receives New York State Approval to Commence Commercial Testing
Jun 08, 2020
Roxadustat Demonstrates Non-Inferiority to Darbepoetin in Phase 3 DOLOMITES Study of Anemia in Non-Dialysis-Dependent Adult Patients with Chronic Kidney Disease
May 28, 2020
Bird Rock Bio Files IND Application for Phase 2 Study of Nimacimab for Treatment of Renal Diseases
May 27, 2020
Kantum Pharma Highlights New Research Demonstrating Beneficial Effects of P2Y14 Antagonist in Acute Kidney Injury
May 20, 2020
European Medicines Agency Accepts Astellas' Marketing Authorization Application for Roxadustat
May 20, 2020
HemaFlo Therapeutics Provides Update on Global Patent Portfolio
May 18, 2020
Akebia Therapeutics Announces Collaboration Partner's Submission of Supplemental New Drug Application for Use of Riona® (ferric citrate hydrate) to Treat Adult Patients with Iron Deficiency Anemia in Japan
May 05, 2020
Akebia Announced Positive Top-Line Results from Global Phase 3 Program of Vadadustat for Treatment of Anemia Due to Chronic Kidney Disease in Adult Patients on Dialysis; Reports First Quarter 2020 Financial Results
Apr 20, 2020
KidneyIntelX(TM) to Predict Major Adverse Kidney Events in COVID-19 Patients
Mar 27, 2020
Important Research Findings Presented During National Kidney Foundation's Annual Spring Clinical Meetings
Mar 26, 2020
Optiflux Dialyzers Show Mean Increase of Serum Albumin in Hemodialysis Patients
Mar 24, 2020
Cricket Health Expands Collaboration with Cigna
Mar 20, 2020
National Kidney Foundation Honors Janssen Pharmaceutical Companies of Johnson & Johnson with 2020 Corporate Innovator Award
Mar 12, 2020
US FDA grants Fast Track designation to Jardiance® for the treatment of chronic kidney disease
Mar 12, 2020
Oxabact® Treatment Combined With Intensive Dialysis Lowers Plasma Oxalate and Halts Disease Progression in a Patient With Severe Infantile Oxalosis
Mar 11, 2020
Improved Cost-effectiveness of Secondary Prevention of Kidney Disease by Targeting Higher Risk Populations
Mar 06, 2020
Ardelyx Reports Fourth Quarter and Full Year 2019 Financial Results and Recent Highlights
Mar 05, 2020
Data on Acthar® Gel (Repository Corticotropin Injection) Therapy in Immunoglobulin A Nephropathy (IgAN) Published in Kidney International Reports